Skip to main content

Amiodarone Injection

Last Updated: January 25, 2023
Status: Current

Products Affected - Description
    • Nexterone injection, Baxter, 150 mg/100 mL, premixed bag, 12 count, NDC 43066-0150-10
    • Nexterone injection, Baxter, 360 mg/200 mL, premixed bag, 10 count, NDC 43066-0360-20
    • Amiodarone injection, Fresenius Kabi, 50 mg/mL, 3 mL vial, 10 count, NDC 63323-0616-03
    • Amiodarone injection, Hikma, 50 mg/mL, 3 mL vial, 25 count, NDC 00143-9875-25
Reason for the Shortage
    • AuroMedics discontinued amiodarone in mid-2021.
    • Baxter has Nexterone premixed bags on shortage due to manufacturing delays.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
    • Viatris did not provide a reason for the shortage.
    • Sagent discontinued amiodarone 50 mg/mL 3 mL syringes in June 2019.
Available Products
    • Amiodarone injection, Fresenius Kabi, 50 mg/mL, 9 mL vial, 10 count, NDC 63323-0616-09
    • Amiodarone injection, Mylan Institutional (Viatris), 50 mg/mL, 18 mL vial, 10 count, NDC 67457-0153-18
    • Amiodarone injection, Mylan Institutional (Viatris), 50 mg/mL, 3 mL vial, 10 count, NDC 67457-0153-03
    • Amiodarone injection, Mylan Institutional (Viatris), 50 mg/mL, 9 mL vial, 10 count, NDC 67457-0153-09

Estimated Resupply Dates

    • Fresenius Kabi has short-dated amiodarone 50 mg/mL 3 mL vials available with an expiration date of < 8 months.
    • Hikma has amiodarone 50 mg/mL 3 mL vials on allocation.
    • Baxter has Nexterone 150 mg/100 mL premixed bags and 360 mg/200 mL premixed bags available in limited supply.

Updated

Updated January 25, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 6, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.